Article

A Predictive Model for Evaluating Efficacy of Immunotherapy in Non-small-cell Lung Cancer Patients

2023-05-02

Abstract excerpt

The predictive accuracy to treatment effect of immune therapy is still poor. Thus, we aimed to develop a predictive model based on gene mutations to assess the immunotherapeutic efficacy in non-small cell lung cancer. Then, 335 NSCLC patients treated with ICIs were included in our study. The least absolute shrinkage and selection operator Cox regression model, multivariable analysis, and Kaplan-Maire test were use...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 284bf5fa-4c43-50d9-be2e-b425f2002a11
DOI: 10.21203/rs.3.rs-2850211/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Predictive Model for Evaluating Efficacy of Immunotherapy in Non-small-cell Lung Cancer PatientsDOI 10.21203/rs.3.rs-2850211/v1Read

A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients.Semantic proximity Read

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.Semantic proximity Read

The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.Semantic proximity Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.Semantic proximity Read

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.Semantic proximity Read

An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer.Semantic proximity Read

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinomaSemantic proximity Read

Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic modelSemantic proximity Read

TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer.Semantic proximity Read

Identification and Validation of a Tumor Microenvironment‐Related Gene Signature for Prognostic Prediction in Advanced‐Stage Non‐Small‐Cell Lung CancerSemantic proximity Read

Using machine learning modeling to explore new immune-related prognostic markers in non-small cell lung cancerSemantic proximity Read